Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-986251 in Healthy Subjects and Psoriasis Patients
NCT03329885Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bms-986251 in psoriasis, sponsored by Bristol Myers Squibb. Started Nov 2017; status: terminated.
02
Drugs
bms-986251
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT03329885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329885.